Generated by AI
Bausch Health Companies Inc. is a diversified specialty pharmaceutical and medical device company focused on developing, manufacturing, and marketing healthcare products across multiple therapeutic areas. Bausch Health serves the gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals, and eye health markets, with a portfolio that includes branded, generic, and over-the-counter medicines as well as medical devices. Its operations are organized around products and services used in treating conditions such as digestive disorders, skin diseases, neurological conditions, and vision-related care. The company also supports hospital and clinic needs through its medical device and ophthalmic businesses. Headquartered in Laval, Quebec, Bausch Health plays a significant role in the global healthcare market by supplying therapies and devices used by patients, physicians, and healthcare providers across the United States and international markets.
Website2150 St. Elzéar Blvd. West
Laval, QC, H7L 4A8
Canada
The latest articles about BHC.
Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, will present a research poster at the American Association for the Study of Liver Diseases' The Liver Meeting® 2026, November 5–9 in Denver, Colorado. The study highlights the substantial mortality and rehospitalization among patients hospitalized with severe alcohol-associated hepatitis (AH).
Bausch Health raises its 2026 revenue, EBITDA and cash flow outlook on strong Q3 results, while flagging Xifaxan pricing risks and inventory headwinds ahead
Bausch Health stock surged 26% after Q3 results, following a raised outlook and a first $1B EBITDA quarter. Here is what drove the rally and what could slow it next. The post What in the World Happened With Bausch Health Stock Last Week? appeared first on The Motley Fool Canada.
Summary of Oct 30's posts. Generated by AI.
Summary of Oct 29's posts. Generated by AI.
Summary of Mar 15's posts. Generated by AI.
Summary of Oct 29's posts. Generated by AI.
Investors talking about BHC also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.